Akimitsu Miyauchi - Concepedia

Author

Akimitsu Miyauchi

Hyogo Chuo National Hospital

Also Known As

A Miyauchi, AKIMITSU MIYAUCHI, Akimitsu MIYAUCHI, Akimitsu Miyauchi, Miyauchi, Akimitsu

Publications

6.6K

Citations

H-Index

Concepts

All Affiliations

Hyogo Chuo National Hospital Kobe University Amgen (United States)UCB Pharma (Belgium)Osaka City University

About

Akimitsu Miyauchi is an author at Hyogo Chuo National Hospital specializing in medicine, osteoporosis, and orthopaedics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	31	2K
2	Health Sciences	6	6	492
3	Engineering	4	4	238
4	Anesthesia	2	2	41
5	Applied Physiology	2	2	156

Akimitsu Miyauchi

Publications

6.4K

Citations

H-Index

Page 1

	Year	Citations
Romosozumab Treatment in Postmenopausal Women with Osteoporosis Felicia Cosman, Daria B. Crittenden, Jonathan D. Adachi, New England Journal of Medicine	2016	1.6K
Fibroblast Growth Factor 23 in Oncogenic Osteomalacia and X-Linked Hypophosphatemia Kenneth B. Jonsson, R Zahradnik, Tobias E. Larsson, New England Journal of Medicine	2003	907
Association of a Polymorphism of the Transforming Growth Factor-β1 Gene with Genetic Susceptibility to Osteoporosis in Postmenopausal Japanese Women Yoshiji Yamada, Akimitsu Miyauchi, Junki Goto, Journal of Bone and Mineral Research	1998	320
The Autosomal Dominant Hypophosphatemic Rickets (ADHR) Gene Is a Secreted Polypeptide Overexpressed by Tumors that Cause Phosphate Wasting Kenneth E. White, Kenneth B. Jonsson, Gwénaëlle Carn, The Journal of Clinical Endocrinology & Metabolism Signal TransductionMolecular PhysiologyFgf-23 MrnaBone Morphogenic ProteinParathyroid Hormone	2001	319
A Phase III Randomized Placebo-Controlled Trial to Evaluate Efficacy and Safety of Romosozumab in Men With Osteoporosis E. Michael Lewiecki, Tomasz Blicharski, Stefan Goemaere, The Journal of Clinical Endocrinology & Metabolism	2018	301
FGF-23 in patients with end-stage renal disease on hemodialysis Yasuo Imanishi, Masaaki Inaba, Kiyoshi Nakatsuka, Kidney International GlomerulonephritisHemodialysisUrologyRenal DiseaseRenal Function	2004	272
One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study E. Michael Lewiecki, Rajani Dinavahi, Marise Lazaretti-Castro, Journal of Bone and Mineral Research SclerostinBone ResorptionOsteoporosisInflammatory ArthritisOrthopaedic Surgery	2018	183
Distinct Anabolic Response of Osteoblast to Low-Intensity Pulsed Ultrasound Kouji Naruse, Akimitsu Miyauchi, Moritoshi Itoman, Journal of Bone and Mineral Research	2003	171
Effects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-Month, randomized, placebo-controlled, double-blind and 12-month open-label phases Akimitsu Miyauchi, Toshio Matsumoto, Toshitsugu Sugimoto, Bone Bone DiseaseBone Turnover MarkersBody CompositionBone HealthHealth Sciences	2010	144
Effect of age on body sway assessed by computerized posturography Takuo Fujita, Shôji Nakamura, Mutsumi Ohue, Journal of Bone and Mineral Metabolism Upright PostureMovement AnalysisKinesiologyGeriatric SpineBody Sway	2005	142

Page 1